Transcription of Addressing specific regulatory excipient …
{{id}} {{{paragraph}}}
Addressing specific regulatory excipientrequirements in the marketing authorizationAddressing specific regulatory excipientrequirements in the marketing authorizationDr. Philipp HebestreitGlobal regulatory AffairsPharma Ingredients & ServicesBASF SEPharmSciFair Nice, June 11th, 2009Dr. Philipp Hebestreit, Pharma Ingredients & Services, BASF SEPresentation PharmSciFair of excipient vs. API registrationzClassification of excipientszExcipient guidancezRegistration challenges of well-known vs. new excipientszThe basis for successful registration: excipient master fileszSafety assessment of excipientszHot topicszIndustry concernszCase study: Registration of a novel excipientzSummary & conclusionDr. Philipp Hebestreit, Pharma Ingredients & Services, BASF SEPresentation PharmSciFair , Manufacturing and ControlsEMEA/ EMA -European Medicines (Evaluation) AgencyAPI-Active Pharmaceutical IngredientFDA-Food and Drug AdministrationCDER-Center for Drug Evaluation and ResearchIIG/ IID-Inactive Ingredient Guide/ -DatabaseDMF/ EMF -Drug Master File/ excipient Master FilePh.
Addressing specific regulatory excipient requirements in the marketing authorization Dr. Philipp Hebestreit Global Regulatory Affairs Pharma Ingredients & Services
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Technical Regulatory Standards on Japanese, Technical Regulatory Standards on Japanese Railways, The Regulatory System of Veterinary, The Regulatory System of Veterinary Drugs, DuPont, Technical, ELECTRIC VEHICLE CHARGING STATIONS, ELECTRIC VEHICLE CHARGING STATIONS Technical, Expert Committee on Biological, Expert Committee on Biological Standardization, Turnkey Construction of Factories in, Article Information Sheet AIS